Norden Group LLC Eli Lilly & CO Transaction History

Norden Group LLC

$495 Billion
Q2 2024

A detailed history of Norden Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Norden Group LLC holds 2,080 shares of LLY stock, worth $1.84 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

2,080

Previous 2,053 1.32%

Holding current value

$1.84 Million

Previous $1.6 Billion 17.93%

% of portfolio

0.38%

Previous 0.32%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $19,571 - $24,544	27 Added 1.32%	2,080 $1.88 Billion
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $20.8 Million - $27.8 Million	-35,045 Reduced 94.47%	2,053 $1.6 Billion
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $21 Million - $28.1 Million	35,416 Added 2105.59%	37,098 $28.9 Billion
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $18,381 - $21,669	-35 Reduced 2.04%	1,682 $980 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $746,379 - $1.03 Million	1,717 New	1,717 $922 Million

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.

Account